Single arm phase II trial evaluating the activity of Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC

ETOP ALERT

Coordinating investigator

MD PhD
Christian
Britschgi
Universitätsspital Zürich
+41 44 255 22 14

For further information about the trial ETOP please visit the ETOP-Website: www.etop-eu.org.

Clinics

All trials